SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix (OCUL) is heavily trending amid high anticipation for imminent topline data from its Phase 3 superiority trial of Axpaxli in wet AMD, with the community widely expecting positive results to drive significant upside. Adding to the bullish sentiment, speculation of a sweetened Sanofi buyout offer, following a rejected previous bid, is fueling active discussion around potential acquisition prices and a forthcoming short squeeze.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending as its board evaluates a revised offer from Paramount Skydance, which includes a ticking fee and covers Netflix's breakup fee, reigniting community debate over which suitor provides superior value and has a clearer regulatory path amidst ongoing antitrust scrutiny for the Netflix deal.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as it announced successful Phase 3 trial results for its COMP360 psilocybin therapy in treatment-resistant depression, showing statistically significant efficacy and a favorable safety profile. The community is actively discussing its potential as the first FDA-approved psychedelic medicine and accelerated commercialization timeline, despite some debate on efficacy magnitude and market volatility.

Energy Transfer LP engages in natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities, and gathering systems and delivery of natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition, and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acquisition, and marketing services to crude oil markets. The Investment in Sunoco LP segment refers to the distribution of motor fuels to independent dealers, distributors, and other commercial customers and the distribution of motor fuels to end-user customers at retail sites. The Investment in USAC segment offers compression services to its customers in connection with infrastructure applications including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. The company was founded by Kelcy L. Warren in 1996 and is headquartered in Dallas, TX.

Energy Transfer LP - Unit

Energy Transfer LP Unit

Energy Transfer is a top discussion point after reporting its Q4 earnings with increased adjusted EBITDA and announcing a dividend hike, even as it navigates an EPS miss and the strategic decision to suspend its Lake Charles LNG project. Investors are closely watching its strong positioning to capitalize on growing natural gas demand, particularly from the expanding AI data center industry and recent cold weather.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

A major acquisition offer for Zim Integrated Shipping Services is driving intense conversation, with many anticipating a significant short squeeze, while others debate the deal's valuation and the crucial factor of Israeli government and worker approval.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic Plc

Medtronic is trending after exceeding Q3 earnings and revenue expectations, driven by strong 6% organic growth and robust performance from its innovation pipeline, notably in cardiac ablation and recent robotic surgery and diabetes technology advancements. The community is noting the reaffirmed full-year guidance as a sign of confidence in the company's accelerated momentum and strategic investments.

eToro Group Ltd. engages in the development, management, and provision of online trading software solutions and services. The firm's trading platform, eToro, allows users to trade financial instruments. It also enables non-professionals to trade in markets that were previously the exclusive arena of professional investors. The company was founded by Johnathan Alexander Assia, Guy Gamzu, David Ring, and Ronen Assia on December 14, 2006 and is headquartered in Bnei Braq, Israel.

Etoro Group Ltd - Ordinary Shares - Class A

eToro Group Ltd

eToro is trending following the announcement of an increased share repurchase program and recent financial updates that have sparked community discussion regarding its perceived undervaluation compared to rivals. Investors are actively debating institutional accumulation and potential market dynamics influencing its current price action.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Churchill Capital Corp X 

CCCX is trending due to its imminent merger with quantum technology leader Infleqtion, set to trade as INFQ on the NYSE. Community sentiment is exceptionally bullish, driven by the SPAC's near-zero redemption rate preserving significant cash, pioneering quantum sensing contracts with NASA, and strategic partnerships, leading many to believe the stock is currently undervalued relative to its peers in the rapidly evolving quantum sector.

Vulcan Materials Co. engages in the production of construction aggregates. It operates through the following segments: Aggregates, Asphalt, and Concrete. The Aggregates segment produces and sells aggregates and related products and services. The Asphalt segment relates to the production and selling of asphalt mix in Arizona, California, New Mexico, Tennessee, and Texas. The Concrete segment refers to the production and selling of ready-mixed concrete in California, Maryland, and Virginia in addition to the U.S. Virgin Islands and Washington D.C. The company was founded in 1909 and is headquartered in Birmingham, AL.

Vulcan Materials Co

Vulcan Materials is trending as its latest earnings, while a mixed bag for the current quarter, highlight a robust outlook for 2026, driven by anticipated strength in public and improving private nonresidential construction markets. The community is focused on the company's strong forward guidance and continued margin expansion, reinforcing a positive long-term view for this aggregates leader.

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Neogenomics Inc.

NeoGenomics is trending as a recent favorable patent ruling on its RaDaR technology is viewed by the community as a major catalyst, eliminating a business threat and unlocking significant growth, further supported by positive earnings reports and analyst upgrades.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

KRSL
Kreisler Manufacturing Corp.

Feed

News

Sentiment

Fundamentals

Info

Latest KRSL News

KRSLKreisler Manufacturing Corp.